Sarcopenia Affects the Clinical Efficacy of Immune Checkpoint Inhibitors in Patients with Gastrointestinal Cancers
The impact of sarcopenia on the efficacy of immune checkpoint inhibitors (ICI) in gastrointestinal cancer (GIC) patients remains uncertain in clinical practice. Hence, this study aims to investigate the potential correlation between sarcopenia and the clinical outcomes of GIC patients treated with ICIs.
Source: Clinical Nutrition - Category: Nutrition Authors: Lilong Zhang, Tianrui Kuang, Man Li, Xinyi Li, Peng Hu, Wenhong Deng, Weixing Wang Tags: Original article Source Type: research